14th Transgenic Technology Meeting

October 1-4, 2017 Salt Lake City,
Utah, USA Snowbird Resort

About ISTT

The International Society for Transgenic Technologies (ISTT) was founded in Spain in 2006, and was incorporated in 2013 in the USA. The ISTT currently has more than 700 members who share in our goals of increased communication and technology sharing to enhance scientific research and to advance the field of animal transgenesis.

The ISTT sponsors a series of periodic international meetings known as the Transgenic Technology (TT) Meetings.

The purpose of the International Society for Transgenic Technologies is to:

  • Advance the science and technologies used in the generation and analysis of transgenic animal models for biomedical research and biotechnology application.
  • Support scientific research, education, and training pertinent to the field of animal transgenesis.
  • Provide the organizational framework for a scientific society that includes academic, industry and/or government scientists, students and technical specialists as well as other persons with an interest in the field of animal transgenesis.
  • Provide a communication and knowledge exchange platform that brings together scientists from academia and industry, as well as research technology experts.
  • Organize a periodic international scientific conference entitled the “Transgenic Technology Meeting”.
  • Participate in national and international conferences, seminars and workshops related to animal transgenesis.
  • Publish informational bulletins, abstracts, monographs, books, protocols, and other specialized texts related to the field of animal model transgenesis.
  • Organize and promote courses, seminars and other educational activities to provide training in transgenic animal technologies.
  • Associate with other national and international societies with similar aims.
  • Provide expert information to the general public regarding the benefits associated with the use and application of transgenic technologies in animals.
  • Provide expert advice and guidance to local, national and international bodies regarding scientific, technical, or other aspects of animal transgenesis.

Board of Directors

Jan Parker-Thornburg

President  (elected 2014, [TT2014-TT2017])
(MD Anderson Cancer Center, Houston, TX, USA)

Benoît Kanzler

Vice-President (elected 2013, [2014-2017/TT2017])
(Max-Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany)

Lynn Doglio

Secretary (elected in 2015, [TT2016-TT2019])
(Northwestern University, Feinberg School of Medicine, Chicago, IL, USA)

Aimee Stablewski

Treasurer  (elected 2014, [TT2014-TT2017])
(Roswell Park Cancer Institute, Buffalo, NY, USA)

Peter Hohenstein

Board Member  (elected in 2015, [TT2016-TT2019])
(The Roslin Institute, Univ. Edinburgh, Midlothian, UK)

Martina Crispo

Board Member (elected in 2014, [TT2014-TT2017])
(Institut Pasteur, Montevideo, Uruguay)

Cheryl Bock

Board Member (elected in 2014, [TT2014-TT2017])
(Duke University Medical Center, Durham, NC, USA)

Karen Brennan

Board Member (elected 2013, [2014-2017/TT2017])
(The Victor Chang Cardiac Res. Inst., Sydney, NSW, Australia)

Elizabeth Williams

Board member (elected 2010, [2011-2014]; re-elected in 2014, [TT2014-TT2017])
(UQ-TASQ, Brisbane, QLS, Australia)

Branko Zevnik

Board Member (elected in 2015, [TT2016-TT2019])
(CECAD, University of Cologne, Germany)

For more information or to join ISTT

click here